Oral News and Research

RSS

Natural compound found in olives can lower blood sugar levels and promote weight loss

Findings from a new mouse study suggest that elenolic acid, a natural compound found in olives, can lower blood sugar levels and promote weight loss.

29 Jun 2024

KFF Health News' 'What the Health?': SCOTUS ruling strips power from federal health agencies

In what will certainly be remembered as a landmark decision, the Supreme Court's conservative majority this week overruled a 40-year-old legal precedent that required judges in most cases to yield to the expertise of federal agencies.

28 Jun 2024

Diabetes decoded: How your gut microbiome influences disease risk

How microbial features and functions specific to subspecies and strains contribute to the pathological mechanisms of type 2 diabetes.

27 Jun 2024

Study finds lower cancer risk with alcohol abstinence and rehabilitation

A new study conducted by the Centre for Addiction and Mental Health (CAMH), Bordeaux University Hospital, France, and the World Health Organization (WHO) has found that individuals with alcohol dependence who undergo rehabilitation or maintain abstinence experience significantly lower risks of developing alcohol-associated cancers.

26 Jun 2024

Specific bacteria in the gut associated with food addiction

An international team of researchers has identified specific bacteria in the gut that are associated with both mice and humans developing an addiction to food that can lead to obesity.

26 Jun 2024

Experts publish guidance to help safely and equitably implement Palforzia peanut oral immunotherapy

Based on focus groups with children and young people with peanut allergy, experts have published guidance for clinicians working in the UK's National Health Service (NHS) to help them safely and equitably implement Palforzia® peanut oral immunotherapy.

26 Jun 2024

Ground falls most common cause of head injury in elderly, new study finds

Falls are the most common cause of injury among adults 65 and older in the United States. According to the U.S. Centers for Disease Control and Prevention, every year, more than 14 million older adults (one in four) report a fall. About 90% of head injuries among older individuals is due to ground-level falls.

26 Jun 2024

Extended-release ketamine tablets offer new hope for treatment-resistant depression

The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most efficacy. The treatment was well-tolerated with minimal side effects.

26 Jun 2024

Study reveals novel therapeutic approach for excessive alcohol use

In a significant finding, researchers from The Jackson Laboratory (JAX) and UConn Health have discovered that sodium valerate, a short-chain fatty acid produced by gut microbes, can dramatically reduce binge drinking behavior and blood ethanol concentration in mice.

25 Jun 2024

Comparative study on preventative SMA therapies shows mixed outcomes

In a first-of-its-kind study, researchers compared the efficacy of preventative therapy for spinal muscular atrophy (SMA) between two well-matched study groups, using either gene therapy (onasemnogene abeparvovec) alone or in combination with risdiplam (oral medication) or nusinersen (intrathecal injection) administered before apparent signs of disease emerged.

25 Jun 2024

Human milk banks improve infant health but can't fully replace mother's milk

Scientists investigate human milk banks and their impact on infant health, highlighting differences between donated and maternal milk in gut microbiota and development.

25 Jun 2024

Ketamine tablets offer new hope for treatment-resistant depression

For those suffering from treatment-resistant depression, the anaesthetic drug ketamine offers hope, but it has side effects and can be costly to access – a University of Otago-led clinical trial may change that.

24 Jun 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).

22 Jun 2024

AI outperforms peers in medical oncology quiz, yet some mistakes could be harmful

The accuracy and safety of large language models (LLMs) in answering medical oncology examination questions.

21 Jun 2024

Young adults with periodontitis at higher risk for cryptogenic ischemic stroke

Periodontitis, a common condition, has been linked to a specific type of ischemic stroke.

20 Jun 2024

Cluster analysis identifies distinct subgroups of gestational diabetes patients

Patients with gestational diabetes show different disease progressions and therefore require personalized treatment measures. An international research team led by MedUni Vienna has now identified three subgroups of the disease with different treatment needs.

19 Jun 2024

Perinatal depression linked to higher long-term cardiovascular disease risk in women

Women diagnosed with perinatal depression are more likely to develop cardiovascular disease in the following 20 years compared to women who have given birth without experiencing perinatal depression, according to research published in the European Heart Journal today (Wednesday).

19 Jun 2024

Early management of gestational diabetes can prevent maternal and child health complications

Speaking at the American Diabetes Association 84th Scientific Sessions, authors of a new Lancet Series challenge current approaches to managing gestational diabetes (a type of diabetes that can be diagnosed during pregnancy) and call for initiating treatment much earlier to prevent complications during pregnancy and beyond.

19 Jun 2024

UQ study aims to reduce life-threatening allergic reactions in adolescents

A University of Queensland project aims to make the teenage years safer for Australian children diagnosed with life-threatening food allergies.

18 Jun 2024

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

A recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.

18 Jun 2024

Oral News and Research

Natural compound found in olives can lower blood sugar levels and promote weight loss

KFF Health News' 'What the Health?': SCOTUS ruling strips power from federal health agencies

Diabetes decoded: How your gut microbiome influences disease risk

Study finds lower cancer risk with alcohol abstinence and rehabilitation

Specific bacteria in the gut associated with food addiction

Experts publish guidance to help safely and equitably implement Palforzia peanut oral immunotherapy

Ground falls most common cause of head injury in elderly, new study finds

Extended-release ketamine tablets offer new hope for treatment-resistant depression

Study reveals novel therapeutic approach for excessive alcohol use

Comparative study on preventative SMA therapies shows mixed outcomes

Human milk banks improve infant health but can't fully replace mother's milk

Ketamine tablets offer new hope for treatment-resistant depression

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

AI outperforms peers in medical oncology quiz, yet some mistakes could be harmful

Young adults with periodontitis at higher risk for cryptogenic ischemic stroke

Cluster analysis identifies distinct subgroups of gestational diabetes patients

Perinatal depression linked to higher long-term cardiovascular disease risk in women

Early management of gestational diabetes can prevent maternal and child health complications

UQ study aims to reduce life-threatening allergic reactions in adolescents

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News